MYNZ Company Profile and Key Details
Mainz Biomed B.V.
MYNZ Stock Price Chart
Stock Price Today
Mainz Biomed B.V. (MYNZ) stock surged +9.34%, trading at $6.09 on NASDAQ, up from the previous close of $5.57. The stock opened at $5.75, fluctuating between $5.69 and $6.80 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Company Information
| Employees | 65 |
| Beta | 0.08 |
| Sales or Revenue | $895.48K |
| 5Y Sales Change% | 1.294% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
Frequently Asked Questions
Mainz Biomed B.V. (NASDAQ: MYNZ) stock price is $6.09 in the last trading session. During the trading session, MYNZ stock reached the peak price of $6.80 while $5.69 was the lowest point it dropped to. The percentage change in MYNZ stock occurred in the recent session was 9.34% while the dollar amount for the price change in MYNZ stock was $0.52.
The NASDAQ listed MYNZ is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Mainz Biomed B.V. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Petra Ploesser Ph.D.
Head of Quality
Mr. Guido Baechler
Chief Executive Officer & Director
Mr. William J. Caragol
Chief Financial Officer
Corinna Gorges
Head of R&D
Mr. Philipp Freese
C.B.O.
Dr. Moritz Eidens Ph.D.
Chief Science Officer & Director
Stefan Erlach
Head of HR
Mr. Darin S. Leigh
Chief Commercial Officer
Dr. Chris Von Torne P.M.P., Ph.D.
Chief Operating Officer
Dr. Frank Krieg-Schneider
Chief Technology Officer
MYNZ's closing price is 3,283.33% higher than its 52-week low of $0.18 where as its distance from 52-week high of $7.95 is -23.4%.
Number of MYNZ employees currently stands at 65.
Official Website of MYNZ is: https://mainzbiomed.com
MYNZ could be contacted at phone 496 131 5542860 and can also be accessed through its website. MYNZ operates from Robert Koch Strasse 50, Mainz, 55129, Germany.
MYNZ stock volume for the day was 358.81K shares. The average number of MYNZ shares traded daily for last 3 months was 2.13M.
The market value of MYNZ currently stands at $13.53M with its latest stock price at $6.09 and 2.22M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com